Cullinan Therapeutics, Inc. - Common Stock (NQ:CGEM)
Price and Volume
Detailed Quote| Volume | 766,859 |
| Open | 15.82 |
| Bid (Size) | 13.75 (100) |
| Ask (Size) | 16.44 (100) |
| Prev. Close | 16.15 |
| Today's Range | 15.39 - 16.03 |
| 52wk Range | 5.680 - 16.74 |
| Shares Outstanding | 42,734,644 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
February 24, 2026
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗
November 28, 2025
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗
November 27, 2025
Which stocks are experiencing notable movement on Monday? ↗
November 24, 2025
Frequently Asked Questions
Is Cullinan Therapeutics, Inc. - Common Stock publicly traded?
Yes, Cullinan Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Cullinan Therapeutics, Inc. - Common Stock trade on?
Cullinan Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cullinan Therapeutics, Inc. - Common Stock?
The ticker symbol for Cullinan Therapeutics, Inc. - Common Stock is CGEM on the Nasdaq Stock Market
What is the current price of Cullinan Therapeutics, Inc. - Common Stock?
The current price of Cullinan Therapeutics, Inc. - Common Stock is 15.73
When was Cullinan Therapeutics, Inc. - Common Stock last traded?
The last trade of Cullinan Therapeutics, Inc. - Common Stock was at 05/15/26 04:00 PM ET
What is the market capitalization of Cullinan Therapeutics, Inc. - Common Stock?
The market capitalization of Cullinan Therapeutics, Inc. - Common Stock is 672.22M
How many shares of Cullinan Therapeutics, Inc. - Common Stock are outstanding?
Cullinan Therapeutics, Inc. - Common Stock has 672M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.